Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12323/5117
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSoleiman, Morvarid-
dc.contributor.authorYari, Hadi-
dc.date.accessioned2021-09-29T11:17:43Z-
dc.date.available2021-09-29T11:17:43Z-
dc.date.issued2021-
dc.identifier.citationKhazar Journal of Science and Technologyen_US
dc.identifier.issn2520-6133-
dc.identifier.urihttp://hdl.handle.net/20.500.12323/5117-
dc.description.abstractBreast cancer is the most common cancer in women, accounting for about one-third of cancer cases in women and approximately 14% of cancer-related death in females in the worldwide. It is of great importance to detect breast cancer in the early stage and avoiding overtreatment in patients who only receive a modest benefit, while suffering from toxic side effects, so aiming early detection, diagnostic strategies are important. Biomarkers that are found in blood, urine or body tissues are mostly useful in evaluating the progression of the disease status after initial chemotherapy and radiotherapy to monitor subsequent treatment strategies. In this review, we discuss the importance of established prognostic factors and predictive biomarkers as well as some emerging biomarkers that are currently undergoing testing for technical validity and clinical utility.en_US
dc.language.isoenen_US
dc.publisherKhazar University Pressen_US
dc.relation.ispartofseriesVol. 5;№ 1-
dc.subjectBreast canceren_US
dc.subjectBiomarkersen_US
dc.subjectdiagnosisen_US
dc.subjectprognosisen_US
dc.titleApproaches to Breast Cancer Diagnosisen_US
dc.typeArticleen_US
Appears in Collections:2021, Vol. 5, № 1

Files in This Item:
File Description SizeFormat 
Approaches to Breast Cancer Diagnosis.pdf344.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.